2039. Incremental
Value of Endoscopy in Identifying Low-Risk Persons with Acute Upper GI
Hemorrhage (UGIH)
IM Gralnek, VA Greater Los Angeles Healthcare System, GS Dulai,
VA Greater Los Angeles Healthcare System, TT Oei, Keck-USC School of
Medicine, J Gornbein, UCLA School of Medicine
Objectives: Investigators
have developed and validated an easy to use score (Blatchford Score, Lancet
2000; 356) for risk-stratifying individuals with acute UGIH. Like the clinical
Rockall Score, the Blatchford Score uses only clinical and lab data.
Proponents of Blatchford Score suggest its use at the point of hospital
admission to identify persons at low-risk for adverse outcomes (<5%
rebleeding and <1% mortality) who could be managed as outpatients. From a
healthcare policy perspective, this could increase efficiency of care and
decrease resource utilization. The complete Rockall Score, is a valid and well-accepted risk
stratification tool that uses both clinical and endoscopic data in
risk-stratifying individuals with acute UGIH. We hypothesized that as compared
to the Blatchford Score, the complete Rockall Score would safely and correctly
identify a greater percentage of low-risk individuals presenting with acute UGIH.
Methods: Using ICD-9
codes for discharge diagnosis, we
identified, at a university tertiary care hospital, a cohort of patients (n=175)
with acute non-variceal UGIH. Medical record data were abstracted by two data
abstractors blinded to study intent. Blatchford and Rockall scores were
generated for each case. Low-risk
cases were defined as Blatchford Score=0, clinical Rockall Score=0, and complete
Rockall Score <=2.
Results: We found that
the Blatchford Score, stratified only 14/175 (8%) of the cohort with acute, non-variceal
UGIH as "low-risk". In
comparison, we found that the clinical Rockall Score (pre-endoscopy) stratified
21/175 (12%) as low-risk and the complete Rockall Score (post-endoscopy)
stratified 53/175 (30%) as low-risk for adverse outcomes. No patient stratifed
as low-risk using the Blatchford Score rebled or died (100% negative predictive
value). 2/53 (3.8%) low-risk patients by the complete Rockall Score had
rebleeding, none died (96.2% NPV).
Conclusions: In this
retrospective cohort study, the complete Rockall Score accurately and safely
identified an additional n=39 (22%) low-risk patients with acute, non-variceal
UGIH. These data suggest that endoscopy is an integral component in identifying
low-risk individuals presenting with acute UGIH and has incremental clinical
value. Moreover, the use of urgent endoscopy may improve efficiency of care and
decrease healthcare resource utilization. We recommend the prospective
comparison and evaluation of these risk stratification tools to confirm these
findings.